Our R&D Division
Our Core R&D Pillars
1. Bio-Active Omega 3.6.9 Ratio
Our flagship formulations Hemor 3.6.9 and Darma 3.6.9 are engineered through proprietary cold-pressed molecular stabilization. We ensure that delicate essential fatty acids maintain 100% bio-potency without oxidative deterioration.
2. HPLC Molecular Verification
Every active compound extracted in Sri Baba Lab is subjected to High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry to confirm zero heavy metals, zero pesticides, and uniform therapeutic dosage.
3. Clinical Trial Protocols
We collaborate with medical institutes across India to conduct double-blind clinical trials. Feedback from practicing dermatologists and physicians directly informs our formulation iterations.
4. ISO Class 5 Cleanroom Extraction
Our laboratory sterile cleanrooms utilize positive pressure HEPA filtration, safeguarding our lipid products against micro-particulate contamination throughout formulation and capping.
Upcoming R&D Pipeline
Neuro-Calm 3.6.9
Phase II Clinical Trials - Cognitive & Nervous System Lipid Support.
Osteo-Flex 3.6.9
Formulation Phase - Joint Cartilage & Anti-Rheumatoid Lipid Complex.
Pediatric Darma Gentle
Stability Phase - Ultra-Mild Dermatological Barrier for Infants.